KemPharm Inc. | Mutual Funds

Mutual Funds that own KemPharm Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Vanguard Total Stock Market Index Fund
255,572
1.59%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
185,181
1.14%
40,700
0%
07/31/2018
77,930
0.49%
0
0.16%
06/30/2018
Fidelity Spartan Extended Market Index Fund
54,249
0.34%
0
0%
07/31/2018
Inver-99, SICAV
47,481
0.3%
15,101
6.11%
03/31/2018
Balaguer 98 de Inversiones, SICAV
39,853
0.25%
7,473
5.21%
03/31/2018
iShares Micro Cap ETF
33,437
0.21%
0
0.02%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
22,782
0.14%
0
0%
07/31/2018
Vanguard Balanced Index Fund
12,000
0.08%
0
0%
07/31/2018
Fidelity Spartan Total Market Index Fund
9,786
0.06%
0
0%
07/31/2018

About KemPharm

View Profile
Address
1180 Celebration Boulevard
Celebration Florida 34747
United States
Employees -
Website http://www.kempharm.com
Updated 07/08/2019
KemPharm, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the discovery and development of proprietary prodrugs. It focuses in the treatment of serious medical conditions such as attention deficit hyperactivity disorder, pain, and other central nervous system disorders through its platform technology known as Ligand Activated Therapy. The company was founded by Christal M.